Study of serum ceruloplasmin and zinc in type 2 diabetes mellitus
Methods: A case-control study was carried out from November 2018 to June 2019 in collaboration between the biochemistry unit at the College of Medicine and the biochemistry unit at the College of Nursing, Hawler Medical University. The study included 100 type 2 diabetic patients (group 1) and 100 healthy individuals (group 2) to evaluate the serum ceruloplasmin and zinc in both groups.
Results: The mean value of serum ceruloplasmin was significantly (P <0.001) higher in type 2 diabetic patients (55.9 ± 1.26 mg/dL) than that of healthy individuals (36.65 ± 0.71 mg/dL). The mean value of serum zinc was significantly (P <0.001) lower in type 2 diabetic patients (39.19 ± 0.46 ug/dL) compared with controls (65.27 ± 2.5 ug/dL). There was a significant positive correlation between serum ceruloplasmin and the age of diabetic patients (P <0.001). There was a significant negative correlation between serum ceruloplasmin and serum zinc of diabetic patients (P <001). There was no significant correlation between serum ceruloplasmin and body mass index of diabetic patients (P = 0.928).
Conclusion: Based on the findings of the present study, we concluded that high serum ceruloplasmin and low zinc were associated with type 2 diabetics.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37:81–90
Public Health Agency of Canada. Diabetes in Canada: Facts and figures from a public health perspective. Ottawa; 2011.
Powers A C. Diabetes mellitus in: Dennis L, Kasper Eugene Braaunwald, Anthony S Fauci, Stephen L Hauser, Dan L, Longo J, Larry Jamson. Harrisons princeples of internal medicine 16th ed. USA, Mc Graw-Hill 2005. P. 2152–80.
Carl A Burits, David E. Bruns. Tietz fundamentals of clinical chemistry and molecular diagnostics. 7th ed. Elsevier; 2015. P. 305–6
Kaku K. Pathophysiology of type 2-diabetes mellitus and its treatment policy. JMAJ 2010; 53(1):41-6.
Robbins C K, Fausto V, Nelson A, Abul K, Cotran RS, Robbins, S L. Pathologic basis of disease 7th edition. Philadelphia, PA: Saunders; 2005. P. 1194-5.
Sreekumari S, Vasudevan DM. Textbook of biochemistry. 4th edition. JAYPEE 2005; 225–6.
- Samokyszyn VM, Miller DM, Reif DW, Aust D: Inhibition of superoxide and ferritin dependent lipid peroxidation by ceruloplasmin. J Biol Chem 2018; 64:21–6.
Song D, Dunaief JL. Retinal iron homeostasis in health and disease. Front Aging Neurosci 2013; 5:24.
Edwards CQ, Williams DA, Cartwright GE. Hereditar hypoceruloplasminemia. Clin Genet 2009; 15:311–6.
Memisogullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with type 2 diabetes mellitus. J Diabetes Complications 2004; 18:193–7.
Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type2 diabetes mellitus. Am J Kidney Dis 2003; 42:53–61.
Shier D, Lewis R, Jackie Br. Hole's Human Anatomy Fourteenth Edition. New York: McGraw Hill Education; 2016. P. 59.
Fleet JC. Zinc, copper, and manganese. In: Stipanuk MH, editor. Biochemical and physiological aspects of human nutrition. New York; Sounders 2000. P. 741–59
Carocho M, Ferreira IC. A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chemical Toxicol 2013; 51:5–25.
Agte VV, Nagmote RV, Tarwadi KV. Comparative in vitro uptake of zinc by erythrocytes of normal vs. type 2 diabetic individuals and the associated factors. Diabetes Nutr Metab 2004; 17:343–9
Ramakrishnan S, Sulochana KN. Manual of medical laboratory techniques. 1st ed. New Dehli, India: JAYPEE. 2012. P. 25–6.
Angelantonio E, Bhupathiraju N. Body-mass index and all-cause mortality: Individual participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016; 388(10046):776–86.
Martin Bland. An introduction to medical statistics. 4th ed. OUP Oxford: 2015. P. 120–35.
World Health Organization. Diabetes. (Accessed March 24, 2021, at: https://www.who.int/health-topics/diabetes#tab=tab_1).
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(1):5–10.
Lee MJ, Jung CH, Kang YM, Jang JE, Leem J, Park JY, et al. Serum ceruloplasmin level as a predictor for the progression of diabetic nephropathy in Korean men with type 2 diabetes mellitus. Diabetes Metab J 2015; 39(3):230–9.
Enomoto M, Adachi H, Hirai Y, Fukami A, Satoh A, Otsuka M, et al. LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone. J Lipids 2011; 1(1):6–10.
Reenu S, Sunil S, Maulik S. Study of impairment in collaboration between ceruloplasmin and transferring in development of complications in type 2 diabetes mellitus. International Journal of Research in Medical Sciences 2016; 4(8):3611–5.
Zargar A, Bashir M, Masoodi S, Laway B, Wani A, Khan A, et al. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J 2002; 23:539–42.
Osman E, Vliyaoglu, Levent K, Nuriye U, Nazife K, Baysal K, et al. Correlation of serum Cu+2, Zn+2, Mg+2 and HbA1c in type 1 and type 2 Diabetes Mellitus. Turk J of Endo and Metab 2004; 8:75–9.
Li YV. Zinc and insulin in pancreatic beta-cells. Endocrine 2014; 45:178–89.
Anetor JI, Senjobi A, Ajose OA, Agbedana EO. Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians. Nutrition and Health 2002; 16:291–300
Singh R, Niaz M, Rastogi S. Current zinc intake and risk of diabetes and coronary heart disease and factors associated with insulin resistance in rural and urban population of North India. J Am Coll Nutr 2000; 17:564–70.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).